Regulation of chronic lymphocytic leukemia (CLL) immunobiology by histone deacetylase 6 (HDAC6)

被引：0
|
作者：
Sahakian, Eva
Maharaj, Kamira
Powers, John
Fonesca, Renee M.
Deng, Susan
Pinilla-Ibraz, Javier
Quayle, Steven N.
Jones, Simon S.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4485
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4485
引用
收藏
页数：4
相关论文
共 50 条
  • [31] HDAC6 is a microtubule-associated deacetylase
    Hubbert, C
    Guardiola, A
    Shao, R
    Kawaguchi, Y
    Ito, A
    Nixon, A
    Yoshida, M
    Wang, XF
    Yao, TP
    [J]. NATURE, 2002, 417 (6887) : 455 - 458
  • [32] Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors
    Senger, Johanna
    Melesina, Jelena
    Marek, Martin
    Romier, Christophe
    Oehme, Ina
    Witt, Olaf
    Sippl, Wolfgang
    Jung, Manfred
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (04) : 1545 - 1555
  • [33] Novel histone deacetylase 6 (HDAC6) selective inhibitors: a patent evaluation (WO2014181137)
    Simoes-Pires, Claudia A.
    Bertrand, Philippe
    Cuendet, Muriel
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2017, 27 (03) : 229 - 236
  • [34] Tau - an inhibitor of deacetylase HDAC6 function
    Perez, Mar
    Santa-Maria, Ismael
    Gomez de Barreda, Elena
    Zhu, Xiongwei
    Cuadros, Raquel
    Roman Cabrero, Jose
    Sanchez-Madrid, Francisco
    Dawson, Hana N.
    Vitek, Michael P.
    Perry, George
    Smith, Mark A.
    Avila, Jesus
    [J]. JOURNAL OF NEUROCHEMISTRY, 2009, 109 (06) : 1756 - 1766
  • [35] HDAC6 is a microtubule-associated deacetylase
    Charlotte Hubbert
    Amaris Guardiola
    Rong Shao
    Yoshiharu Kawaguchi
    Akihiro Ito
    Andrew Nixon
    Minoru Yoshida
    Xiao-Fan Wang
    Tso-Pang Yao
    [J]. Nature, 2002, 417 : 455 - 458
  • [36] Novel Selective Histone Deacetylase 6 (HDAC6) Inhibitors: A Patent Review (2016-2019)
    He, Xingrui
    Li, Zhen
    Zhuo, Xiao-Tao
    Hui, Zi
    Xie, Tian
    Ye, Xiang-Yang
    [J]. RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2020, 15 (01) : 32 - 48
  • [37] HTLV-1 inhibits stress granules formation by interacting with the histone deacetylase 6 (HDAC6)
    Legros, Sebastien
    Boxus, Mathieu
    Twizere, Jean-Claude
    Dequiedt, Franck
    Kettmann, Richard
    [J]. RETROVIROLOGY, 2009, 6
  • [38] HTLV-1 inhibits stress granules formation by interacting with the histone deacetylase 6 (HDAC6)
    Sébastien Legros
    Mathieu Boxus
    Jean-Claude Twizere
    Franck Dequiedt
    Richard Kettmann
    [J]. Retrovirology, 6
  • [39] Inhibition of Histone Deacetylase 6 activity provides protection against atherogenesis: A role of HDAC6 NEDDylation
    Nomura, Yohei
    Rossberg, Max C.
    Bhatta, Anil
    Romer, Lew
    Berkowitz, Dan
    Pandey, Deepesh
    [J]. FASEB JOURNAL, 2018, 32 (01):
  • [40] Inhibition of Histone Deacetylase 6 Activity Provides Protection Against Atherogenesis: a Role for HDAC6 NEDDylation
    Nomura, Yohei
    Rossberg, Max C.
    Bhatta, Anil
    Romer, Lew
    Berkowitz, Dan
    Pandey, Deepesh
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38
12345